US Stock MarketDetailed Quotes

SAGE Sage Therapeutics

Watchlist
  • 7.140
  • -0.040-0.56%
Close Feb 14 16:00 ET
  • 7.160
  • +0.020+0.28%
Post 20:01 ET
438.97MMarket Cap-1.08P/E (TTM)

Sage Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
-52.30%41.24M
-83.56%12.82M
337.08%11.87M
249.80%8.65M
139.89%7.9M
1,024.84%86.46M
2,621.54%77.97M
56.18%2.72M
64.82%2.47M
108.22%3.29M
Operating revenue
-65.81%3.57M
-77.73%442K
-68.96%843K
-75.61%600K
-48.69%1.69M
36.01%10.45M
-30.72%1.99M
56.18%2.72M
63.89%2.46M
108.22%3.29M
Cost of revenue
337.42%9.44M
81.59%1.49M
483.20%5.28M
586.34%1.41M
451.74%1.27M
165.56%2.16M
473.43%820K
391.85%905K
2.50%205K
-19.58%230K
Gross profit
-62.28%31.8M
-85.32%11.33M
264.05%6.59M
219.39%7.25M
116.48%6.63M
1,126.48%84.3M
2,734.39%77.15M
16.46%1.81M
74.40%2.27M
136.42%3.06M
Operating expense
-29.88%442.32M
-23.25%91.67M
-40.13%107.8M
-31.37%118.55M
-21.59%124.31M
13.88%630.76M
-23.74%119.44M
25.89%180.06M
33.13%172.73M
27.34%158.53M
Selling and administrative expenses
-21.17%216.42M
-0.84%54.65M
-31.89%53.22M
-25.91%55.98M
-19.99%52.57M
20.56%274.52M
-18.15%55.11M
27.10%78.14M
36.04%75.57M
41.38%65.71M
-General and administrative expense
-21.17%216.42M
-0.84%54.65M
-31.89%53.22M
-25.91%55.98M
-19.99%52.57M
--274.52M
--55.11M
27.10%78.14M
36.04%75.57M
41.38%65.71M
Research and development costs
-36.59%225.9M
-42.45%37.02M
-46.45%54.58M
-35.61%62.56M
-22.72%71.73M
9.22%356.24M
-27.96%64.33M
24.97%101.92M
25.70%97.16M
18.98%92.83M
Operating profit
24.88%-410.52M
-89.99%-80.34M
43.22%-101.2M
34.70%-111.3M
24.31%-117.68M
0.10%-546.46M
72.52%-42.29M
-25.99%-178.25M
-32.71%-170.46M
-26.19%-155.47M
Net non-operating interest income expense
-18.24%31.68M
-32.42%6.4M
-25.62%7.64M
-17.12%8.43M
4.24%9.2M
173.03%38.74M
39.36%9.47M
148.95%10.27M
383.97%10.17M
655.99%8.83M
Non-operating interest income
-18.24%31.68M
-32.42%6.4M
-25.62%7.64M
-17.12%8.43M
4.24%9.2M
173.03%38.74M
39.36%9.47M
148.95%10.27M
383.97%10.17M
655.99%8.83M
Other net income (expense)
35.37%-21.83M
-19,254.39%-21.84M
100.03%9K
136.59%15K
93.62%-12K
-225,226.67%-33.77M
408.11%114K
-112,280.00%-33.65M
-191.11%-41K
-683.33%-188K
Special income (charges)
34.54%-21.85M
-10,360.09%-21.85M
--0
----
----
---33.39M
--213K
---33.6M
----
----
-Less：Restructuring and merger&acquisition
-34.54%21.85M
10,360.09%21.85M
--0
----
----
--33.39M
---213K
--33.6M
----
----
Other non- operating income (expenses)
107.57%29K
118.18%18K
116.36%9K
136.59%15K
93.62%-12K
-2,653.33%-383K
-167.57%-99K
-283.33%-55K
-191.11%-41K
-683.33%-188K
Income before tax
26.01%-400.67M
-192.85%-95.78M
53.60%-93.55M
35.85%-102.85M
26.12%-108.48M
-1.63%-541.49M
77.77%-32.71M
-46.83%-201.63M
-26.94%-160.33M
-20.30%-146.83M
Income tax
Net income
26.01%-400.67M
-192.85%-95.78M
53.60%-93.55M
35.85%-102.85M
26.12%-108.48M
-1.63%-541.49M
77.77%-32.71M
-46.83%-201.63M
-26.94%-160.33M
-20.30%-146.83M
Net income continuous Operations
26.01%-400.67M
-192.85%-95.78M
53.60%-93.55M
35.85%-102.85M
26.12%-108.48M
-1.63%-541.49M
77.77%-32.71M
-46.83%-201.63M
-26.94%-160.33M
-20.30%-146.83M
Minority interest income
Net income attributable to the parent company
26.01%-400.67M
-192.85%-95.78M
53.60%-93.55M
35.85%-102.85M
26.12%-108.48M
-1.63%-541.49M
77.77%-32.71M
-46.83%-201.63M
-26.98%-160.33M
-20.30%-146.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
26.01%-400.67M
-192.85%-95.78M
53.60%-93.55M
35.85%-102.85M
26.12%-108.48M
-1.63%-541.49M
77.77%-32.71M
-46.83%-201.63M
-26.98%-160.33M
-20.30%-146.83M
Basic earnings per share
27.18%-6.59
-188.89%-1.56
54.60%-1.53
36.57%-1.7
26.83%-1.8
-0.78%-9.05
78.14%-0.54
-45.89%-3.37
-25.82%-2.68
-18.84%-2.46
Diluted earnings per share
27.18%-6.59
-188.89%-1.56
54.60%-1.53
36.57%-1.7
26.83%-1.8
-0.78%-9.05
78.14%-0.54
-45.89%-3.37
-25.82%-2.68
-18.84%-2.46
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue -52.30%41.24M-83.56%12.82M337.08%11.87M249.80%8.65M139.89%7.9M1,024.84%86.46M2,621.54%77.97M56.18%2.72M64.82%2.47M108.22%3.29M
Operating revenue -65.81%3.57M-77.73%442K-68.96%843K-75.61%600K-48.69%1.69M36.01%10.45M-30.72%1.99M56.18%2.72M63.89%2.46M108.22%3.29M
Cost of revenue 337.42%9.44M81.59%1.49M483.20%5.28M586.34%1.41M451.74%1.27M165.56%2.16M473.43%820K391.85%905K2.50%205K-19.58%230K
Gross profit -62.28%31.8M-85.32%11.33M264.05%6.59M219.39%7.25M116.48%6.63M1,126.48%84.3M2,734.39%77.15M16.46%1.81M74.40%2.27M136.42%3.06M
Operating expense -29.88%442.32M-23.25%91.67M-40.13%107.8M-31.37%118.55M-21.59%124.31M13.88%630.76M-23.74%119.44M25.89%180.06M33.13%172.73M27.34%158.53M
Selling and administrative expenses -21.17%216.42M-0.84%54.65M-31.89%53.22M-25.91%55.98M-19.99%52.57M20.56%274.52M-18.15%55.11M27.10%78.14M36.04%75.57M41.38%65.71M
-General and administrative expense -21.17%216.42M-0.84%54.65M-31.89%53.22M-25.91%55.98M-19.99%52.57M--274.52M--55.11M27.10%78.14M36.04%75.57M41.38%65.71M
Research and development costs -36.59%225.9M-42.45%37.02M-46.45%54.58M-35.61%62.56M-22.72%71.73M9.22%356.24M-27.96%64.33M24.97%101.92M25.70%97.16M18.98%92.83M
Operating profit 24.88%-410.52M-89.99%-80.34M43.22%-101.2M34.70%-111.3M24.31%-117.68M0.10%-546.46M72.52%-42.29M-25.99%-178.25M-32.71%-170.46M-26.19%-155.47M
Net non-operating interest income expense -18.24%31.68M-32.42%6.4M-25.62%7.64M-17.12%8.43M4.24%9.2M173.03%38.74M39.36%9.47M148.95%10.27M383.97%10.17M655.99%8.83M
Non-operating interest income -18.24%31.68M-32.42%6.4M-25.62%7.64M-17.12%8.43M4.24%9.2M173.03%38.74M39.36%9.47M148.95%10.27M383.97%10.17M655.99%8.83M
Other net income (expense) 35.37%-21.83M-19,254.39%-21.84M100.03%9K136.59%15K93.62%-12K-225,226.67%-33.77M408.11%114K-112,280.00%-33.65M-191.11%-41K-683.33%-188K
Special income (charges) 34.54%-21.85M-10,360.09%-21.85M--0-----------33.39M--213K---33.6M--------
-Less：Restructuring and merger&acquisition -34.54%21.85M10,360.09%21.85M--0----------33.39M---213K--33.6M--------
Other non- operating income (expenses) 107.57%29K118.18%18K116.36%9K136.59%15K93.62%-12K-2,653.33%-383K-167.57%-99K-283.33%-55K-191.11%-41K-683.33%-188K
Income before tax 26.01%-400.67M-192.85%-95.78M53.60%-93.55M35.85%-102.85M26.12%-108.48M-1.63%-541.49M77.77%-32.71M-46.83%-201.63M-26.94%-160.33M-20.30%-146.83M
Income tax
Net income 26.01%-400.67M-192.85%-95.78M53.60%-93.55M35.85%-102.85M26.12%-108.48M-1.63%-541.49M77.77%-32.71M-46.83%-201.63M-26.94%-160.33M-20.30%-146.83M
Net income continuous Operations 26.01%-400.67M-192.85%-95.78M53.60%-93.55M35.85%-102.85M26.12%-108.48M-1.63%-541.49M77.77%-32.71M-46.83%-201.63M-26.94%-160.33M-20.30%-146.83M
Minority interest income
Net income attributable to the parent company 26.01%-400.67M-192.85%-95.78M53.60%-93.55M35.85%-102.85M26.12%-108.48M-1.63%-541.49M77.77%-32.71M-46.83%-201.63M-26.98%-160.33M-20.30%-146.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 26.01%-400.67M-192.85%-95.78M53.60%-93.55M35.85%-102.85M26.12%-108.48M-1.63%-541.49M77.77%-32.71M-46.83%-201.63M-26.98%-160.33M-20.30%-146.83M
Basic earnings per share 27.18%-6.59-188.89%-1.5654.60%-1.5336.57%-1.726.83%-1.8-0.78%-9.0578.14%-0.54-45.89%-3.37-25.82%-2.68-18.84%-2.46
Diluted earnings per share 27.18%-6.59-188.89%-1.5654.60%-1.5336.57%-1.726.83%-1.8-0.78%-9.0578.14%-0.54-45.89%-3.37-25.82%-2.68-18.84%-2.46
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Argo Blockchain
ARBK
+5.33%
Strategy
MSTR
+3.94%
BTCS Inc
BTCS
+3.20%
Canaan
CAN
+2.29%
Bit Origin
BTOG
+1.90%

Unlock the Full List